Illumina, Inc. is a leading global biotechnology company, established in 1998 and headquartered in San Diego, California. The company specializes in developing innovative technologies and integrated systems for genomic analysis, focusing on sequencing, genotyping, and gene expression solutions. Illumina's products serve a diverse range of markets, including research, clinical, and agricultural applications, driving advancements in personalized medicine and genomics. As a pioneer in the industry, Illumina continues to shape the future of genetic research and diagnostics with its commitment to improving human health through advanced genomic technologies.

NASDAQ

USA

HEALTHCARE

DIAGNOSTICS & RESEARCH

5200 ILLUMINA WAY, SAN DIEGO, CA, UNITED STATES, 92122

December

$15.7 Billion

$1.14 Billion

12.93

7.9

$0.00

0.0%

1.398